Abstract
Introduction: Significant neovascularization following indirect revascularization procedures, such as encephaloduroarteriosynangiosis (EDAS), has traditionally been considered to develop slowly over time. However, a recent study of angiography following indirect revascularization procedures demonstrated early signs of revascularization as early as 4 days following surgery. While we have previously published demonstration of robust revascularization at 6 months and later following surgery, here we present a subset of patients, all with non-moyamoya intracranial arterial stenosis (IAS), with earlier angiographic evaluation following EDAS. Methods: We retrospectively reviewed charts of adult patients who have undergone EDAS for non-moyamoya IAS. These early angiograms were evaluated for signs of revascularization and graded according to the scale presented by Perren et al (1, no sign of neoangiogenesis; 2, one-to-four new transcortical vessels; 3, > four new transcortical vessels). Results: Ten patients (mean age 43 years, 8 females) were found with follow-up cerebral angiography within 6 months of surgery (1 each at 1, 2 & 3 mo, 2 at 1.5 mo, 3 at 5 mo, and 4 at 6 mo). All angiograms demonstrated neovascularity, regardless of underlying diagnosis, including scores of 3 (extensive neoangiogenesis) in 80% of cases as early as 1.5 months after surgery. Two patients had grade 2 at 1 & 2 months. Clinically, all patients’ ischemic symptomatology has resolved. Six patients have had no symptoms since surgery while 4 patients had transient episodes consistent with ischemia (TIA) that all resolved by 2 weeks post-operatively (3 at 1 week and 1 at 2 weeks). No patient suffered stroke following EDAS. Conclusion: This series adds to the growing evidence that indirect revascularization procedures can lead to significant neovascularity in a shorter time frame than previously expected in adult patients, including those with non-moyamoya IAS. Further study is required to better define the time course of neoangiogenesis and to evaluate angiogenic mechanisms that contribute to the success of this procedure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.